Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.34
-0.07 (-0.94%)
At close: Oct 6, 2025, 4:00 PM EDT
7.30
-0.04 (-0.54%)
After-hours: Oct 6, 2025, 7:57 PM EDT

Gyre Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Gyre Therapeutics stock has a target of 18, which predicts a 145.23% increase from the current stock price of 7.34.

Price Target: $18 (+145.23%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$18$18$18$18
Change+145.23%+145.23%+145.23%+145.23%
* Price targets were last updated on Aug 26, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Gyre Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingAug '25Sep '25
Strong Buy11
Buy00
Hold00
Sell00
Strong Sell00
Total11

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$18
Strong BuyInitiates$18+145.23%Aug 26, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
123.52M
from 105.76M
Increased by 16.80%
Revenue Next Year
185.64M
from 123.52M
Increased by 50.29%
EPS This Year
0.13
from 0.05
Increased by 175.81%
EPS Next Year
0.28
from 0.13
Increased by 111.54%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
102.29M113.45M105.76M123.52M185.64M132.40M
Revenue Growth
-10.91%-6.78%16.80%50.29%-28.68%
EPS
0.03-1.410.050.130.28-0.09
EPS Growth
---175.81%111.54%-
Forward PE
---55.3526.17-
No. Analysts
---444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High128.3M249.9M
Avg123.5M185.6M
Low117.6M123.5M

Revenue Growth

Revenue Growth202520262027
High
21.3%
102.3%
Avg
16.8%
50.3%
Low
11.2%
-0.0%

EPS Forecast

EPS202520262027
High0.180.54
Avg0.130.28
Low0.090.04

EPS Growth

EPS Growth202520262027
High
271.3%
303.8%
Avg
175.8%
111.5%
Low
83.5%
-70.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.